The pressor and myotropic effects and the antagonistic properties of several analogues of angiotensin II.
D000109:Acetylcholine / Q000494:pharmacology; D000409:Alanine / Q000494:pharmacology; D000595:Amino Acid Sequence; D000596:Amino Acids / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000494:pharmacology; D002264:Carboxylic Acids / Q000494:pharmacology; D003106:Colon / Q000187:drug effects; D003517:Cyclopentanes / Q000494:pharmacology; D004336:Drug Antagonism; D004837:Epinephrine / Q000494:pharmacology; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects; D008239:Lysine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013270:Stomach / Q000187:drug effects; D013329:Structure-Activity Relationship; D014667:Vasopressins / Q000494:pharmacology
D000596:Amino Acids; D002264:Carboxylic Acids; D003517:Cyclopentanes; D014667:Vasopressins; D000804:Angiotensin II; D012701:Serotonin; D008239:Lysine; D000109:Acetylcholine; D000409:Alanine; D001920:Bradykinin; D009638:Norepinephrine; D004837:Epinephrine